What started as a best practice for the inhibitor community will also be continued in the European Rare and Inhibitor Network (ERIN) context. Each peer-to-peer group will be moderated by a member of the ERIN working group, an experienced patient representative or EHC staff where relevant. The sessions will be open to peers only. Register here.